Summary of Significant Accounting Policies | 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant inter-company transactions and balances have been eliminated in consolidation. Preparation of Financial Statements and Use of Estimates The accompanying financial statements have been prepared by the Company, and reflect all adjustments, which, in the opinion of management, are necessary for fair presentation. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the financial statements and the reported amounts of income and expenses during the reporting periods. Actual results may differ from those estimates and such differences may be material to the consolidated financial statements. Such estimates relate to fair values ascribed to revenue recognition, the allowance for doubtful accounts, inventory valuation, depreciation, product warranty costs, stock-based compensation and income taxes, among others. Revenue Recognition The Company recognizes revenue based on guidance provided in Topic 605, Revenue Recognition Multiple-Deliverable Revenue Arrangements Revenue related to equipment sales is recognized when: (a) the Company has a written sales agreement; (b) delivery has occurred or service has been rendered; (c) the price is fixed or determinable; (d) collectability is reasonably assured; (e) the equipment delivered is a standard product with historically demonstrated acceptance; and (f) there is no unique customer acceptance provision or payment tied to acceptance or an undelivered element significant to the functionality of the system. Generally, payment terms are time based after product shipment. From time to time, sales to a customer may involve multiple elements, in which case revenue is recognized on the delivered element provided that (1) the undelivered element is a proven technology, (2) there is a history of acceptance on the equipment with the customer, (3) the undelivered element is not essential to the customer’s application, (4) the delivered item(s) has value to the customer on a stand-alone basis, and (5) if the arrangement includes a general right of return relative to the delivered item(s), delivery or performance of the undelivered item(s) is considered probable and substantially in the control of the Company. The arrangement consideration, or the amount of revenue to be recognized on each separate unit of accounting, is allocated at the inception of the arrangement to all deliverables on the basis of their relative selling price. Revenue related to maintenance and service contracts is recognized ratably over the duration of the contracts. Net service sales as presented in the Company’s Consolidated Statement of Operations and Comprehensive Income (Loss) includes revenue associated with LTX-Credence maintenance or service contracts only, and excludes ECT and Multitest. ECT and Multitest generally do not provide maintenance and service contracts, but rather sell spare parts and other components, and as a result these sales are recognized as net product sales in the Company’s Consolidated Statement of Operations and Comprehensive Income (Loss). Revenue related to spare parts and components is recognized when the main criteria listed above are met. Generally customer acceptance is not required for spare parts and component sales. Inventories Inventories are stated at the lower of cost or market, determined on the first-in, first-out (“FIFO”) method, and include materials, labor and manufacturing overhead. The components of inventories, excluding the Interface Board Business, are as follows: As of July 31, 2016 2015 (in thousands) Material and purchased components $ 27,753 $ 27,249 Work-in-process 20,218 15,250 Finished equipment, including inventory consigned to customers 22,015 18,094 Total inventories $ 69,986 $ 60,593 The Company establishes inventory reserves when conditions exist that indicate inventory may be in excess of anticipated demand or is obsolete based upon assumptions about future demand for the Company’s products or market conditions. The Company regularly evaluates its ability to realize the value of inventory based on a combination of factors including the following: forecasted sales or usage, estimated product end of life dates, estimated current and future market value and new product introductions. Purchasing and usage alternatives are also explored to mitigate inventory exposure. When recorded, reserves are intended to reduce the carrying value of inventory to its net realizable value. As of July 31, 2016 and July 31, 2015, inventory is stated net of inventory reserves of $21.4 million and $46.9 million, respectively. If actual demand for products deteriorates or market conditions are less favorable than projected, additional inventory reserves may be required. Such reserves are not reversed until the related inventory is sold or otherwise disposed. The following table shows sales of previously reserved inventory and the inventory reserves released for these sales for the fiscal years ended July 31, 2016, 2015, and 2014: Fiscal Year Ended July 31, 2016 2015 2014 (in thousands) Sales of previously reserved inventory $ 3,822 $ 1,664 $ 821 Inventory reserves released for these sales 826 643 483 Goodwill and Other Intangibles In accordance with FASB ASC Topic 350— Intangibles—Goodwill and Other In accordance with ASC 350, the Company performed its goodwill impairment test as of July 31, 2016 and 2015, and determined that no adjustment to goodwill was necessary. As of July 31, 2016, the fair value of the reporting units to which goodwill is allocated substantially exceeded the carrying values of those reporting units. The observable inputs used in the Company’s Discounted Cash Flow (DCF) method for estimating the fair value of the reporting units include discount rates at the Company’s weighted-average cost of capital. The Company derives discount rates that are commensurate with the risks and uncertainties inherent in its respective businesses and its internally developed projections of future cash flows. In addition, the Company determined the projected future cash flows of the reporting units for the residual period using the Gordon growth method which assumes that the reporting unit will grow and generate free cash flow at a constant rate. The Company believes that the Gordon growth method is the most appropriate method for determining the residual value because the residual value is calculated at the point at which the Company has assumed that the reporting units have reached stable growth rates. The Company’s goodwill consists of the following: Goodwill July 31, July 31, (in thousands) Semiconductor Test Reporting Unit Merger with Credence Systems Corporation (August 29, 2008) $ 28,662 $ 28,662 Acquisition of Step Tech Inc. (June 10, 2003) 14,368 14,368 Contactors Reporting Unit Acquisition of Titan Semiconductor Tool LLC (February 2, 2015) 820 820 Total goodwill $ 43,850 $ 43,850 Amortizable intangible assets which relate to the acquisition of Titan Semiconductor Tool LLC (“Titan”), ECT, Multitest, and atg-Luther & Maelzer, and the merger with Credence Systems Corporation (“Credence”), consist of the following, and are included in intangibles asset, net on the Company’s Consolidated Balance Sheets: As of July 31, 2016 Description Estimated Gross Carrying Accumulated Net Amount (in years) (in thousands) (in thousands) (in thousands) Developed technology (Credence, ECT, Multitest, atg-Luther & Maelzer, and Titan) 6-20 $ 29,882 $ (27,605 ) $ 2,277 Customer Relationships—ECT, Multitest, atg-Luther & Maelzer, and Titan 2 1,844 (1,174 ) 670 Maintenance agreements—ASL & Diamond 7 1,900 (1,900 ) — Trade Names 10 70 (15 ) 55 Non-compete Agreements 1 8 (8 ) — Total amortizable intangible assets $ 33,704 $ (30,702 ) $ 3,002 As of July 31, 2015 Description Estimated Gross Carrying Accumulated Net Amount (in years) (in thousands) (in thousands) (in thousands) Developed technology (Credence, ECT, Multitest, atg-Luther & Maelzer, and Titan) 6-20 $ 29,882 $ (26,856 ) $ 3,026 Customer Relationships—ECT, Multitest, atg-Luther & Maelzer, and Titan 2 1,844 (992 ) 852 Maintenance agreements—ASL & Diamond 7 1,900 (1,629 ) 271 Trade Names 10 70 (6 ) 64 Non-compete Agreements 1 8 (8 ) — Total amortizable intangible assets $ 33,704 $ (29,491 ) $ 4,213 Intangible assets, other than trademarks owned by the Company, are amortized based upon the pattern of estimated economic use over their estimated useful lives. The weighted average estimated remaining useful life over which these intangible assets will be amortized is 3.5 years. The Company expects the remaining amortization for these intangible assets as of July 31, 2016 to be: Year ending July 31, Amount 2017 676 2018 548 2019 517 2020 403 Thereafter 858 Total $ 3,002 The identifiable intangible assets associated with the Dover Acquisition include $6.4 million of trademarks. The Company believes these trademarks will contribute to the Company’s cash flows indefinitely. Therefore, in accordance with ASC 350, the Company has assigned an indefinite useful life to the trademarks, and will not amortize the trademarks until their useful lives are no longer indefinite. These assets are subject to an annual impairment test or more frequently if triggering events occur. For the year ended July 31, 2016, the Company assessed qualitative factors to determine if a two-step quantitative impairment test was necessary. The Company determined, based on qualitative assessment, that it was more likely than not that the trademarks’ fair value was greater than their carrying amount, therefore no quantitative assessment was required, and there was no adjustment to the carrying value of the trademarks. Long Lived Assets On an ongoing basis, management reviews the value of and period of amortization or depreciation of the Company’s long-lived assets. In accordance with Topic 360, Property, Plant and Equipment Foreign Currency Remeasurement The financial statements of the Company’s foreign subsidiaries are remeasured in accordance with Topic 830, Foreign Currency Matters, Product Warranty Costs Certain of the Company’s products are sold with warranty provisions that require it to remedy deficiencies in quality or performance of products over a specified period of time at no cost to its customers. The Company generally offers a warranty for most of its products, the standard terms and conditions of which are based on the product sold and the customer. For all products sold, subject to a warranty, the Company accrues a liability for the estimated cost of standard warranty at the time of shipment. Factors that impact the warranty liability include the number of installed products, historical and anticipated product failure rates, material usage and service labor costs. The Company periodically assesses the adequacy of its recorded liability and adjusts these amounts as necessary. The following table shows the change in the Company’s product warranty liability, as required by Topic 460, Guarantees, Product Warranty Activity 2016 2015 (in thousands) Balance at beginning of period $ 2,983 $ 3,206 Warranty expenditures for current period (4,735 ) (5,468 ) Translation adjustment (12 ) (299 ) Provision for warranty costs in the period 4,489 5,544 Balance at end of period $ 2,725 $ 2,983 Trade Accounts Receivable and Allowance for Doubtful Accounts Trade accounts receivable are recorded at the invoiced amount, do not bear interest, and typically have a contractual maturity of ninety days or less. A majority of the Company’s trade receivables are derived from sales to large multinational semiconductor manufacturers throughout the world. The volatility of the industries that the Company serves can cause certain of its customers to experience shortages of cash, which can impact their ability to make required payments. An allowance for doubtful accounts is maintained for potential credit losses based upon the Company’s assessment of the expected collectability of all accounts receivable. The allowance for doubtful accounts is reviewed periodically to assess the adequacy of the allowances. In any circumstances in which the Company is aware of a customer’s inability to meet its financial obligations, an allowance is provided, which is based on the age of the receivables, the circumstances surrounding the customer’s financial situation, and historical experience. If circumstances change, and the financial condition of customers is adversely affected resulting in their inability to meet their financial obligations to the Company, additional allowances may be recorded. Engineering and Product Development Costs The Company expenses all engineering and product development costs as incurred. Expenses relating to certain software development costs, which were subject to capitalization in accordance with the Topic 985, Software, Shipping and Handling Costs Shipping and handling costs are included in cost of sales in the Consolidated Statement of Operations and Comprehensive Income (Loss). Shipping and handling costs were $6.4 million, $7.1 million, and $4.5 million for fiscal years ended July 31, 2016, 2015, and 2014, respectively. Income Taxes The Company recorded an income tax benefit of $1.7 million for fiscal 2016, primarily due to foreign taxes in profitable locations and includes a tax benefit associated with the intraperiod tax allocation. The Company recorded an income tax provision of $2.6 million for fiscal 2015 primarily due to operating results of profitable foreign entities in jurisdictions primarily in Asia and Europe. As of both July 31, 2016 and July 31, 2015, our liability for unrecognized income tax benefits was $6.3 million (of which $2.7 million, if recognized, would impact our income tax rate). The Company recognizes interest and penalties related to uncertain tax positions as a component of provision for income taxes. For July 31, 2016 and July 31, 2015, the Company had accrued approximately $1.2 million and $1.0 million, respectively, for potential payment of accrued interest and penalties. The Company conducts business globally and, as a result, the Company and its subsidiaries or branches file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. In the normal course of business, the Company is subject to examination by taxing authorities throughout the world, including such major jurisdictions as the United States, Singapore, Malaysia, China, France and Germany. With few exceptions, the Company is no longer subject to U.S. federal, state and local or non-U.S. income tax examinations for years prior to 1998. As a result of the Company’s merger with Credence on August 29, 2008, a greater than 50% cumulative ownership change in both entities triggered a significant limitation on net operating loss carryforward utilization. The Company’s ability to use the acquired U.S. net operating loss and credit carryforwards is subject to annual limitation as defined in sections 382 and 383 of the Internal Revenue Code. The Company currently estimates that the annual limitation on its use of net operating losses generated through August 29, 2008 is approximately $10.1 million which, based on currently enacted federal carryforward periods, limits the amount of net operating losses that are available for utilization to approximately $202.0 million. The Company will continue to assess the realizability of these carryforwards in subsequent periods. Accounting for Stock-Based Compensation The Company has equity awards outstanding under various stock-based compensation plans, including the 2010 Stock Plan (“2010 Plan”), 2004 Stock Plan, 2001 Stock Plan, 1999 Stock Plan, and 1993 Stock Plan. In addition, the Company assumed the Credence 2005 Stock Incentive Plan in connection with its acquisition of Credence. The Company can only grant awards from the 2010 Plan. During fiscal 2016, the Company granted 838,300 Restricted Stock Units (“RSUs”) to certain executives, directors and employees, with time-based vesting terms ranging from one to four years. Of these, 305,000 RSUs were granted to executives. The Company recognizes stock-based compensation expense on its equity awards in accordance with the provisions of Topic 718, Compensation—Stock Compensation, For the fiscal years ended July 31, 2016, 2015, and 2014, the Company recorded stock-based compensation expense as follows: Fiscal Year Ended July 31, 2016 2015 2014 (in thousands) Cost of sales $ 216 $ 224 $ 164 Engineering and product development expenses 897 913 632 Selling, general and administrative expenses 5,656 6,414 4,623 Total stock-based compensation expense $ 6,769 $ 7,551 $ 5,419 As of July 31, 2016, there was approximately $10.4 million of unrecognized stock-based compensation expense related to share-based equity grants to employees that is expected to be recognized over the next 2.59 weighted-average years. Net income per Share Basic net income per common share is computed by dividing net income available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net income per common share reflects the maximum dilution that would have resulted from the assumed exercise and share repurchase related to dilutive stock options and RSUs, and is computed by dividing net income by the weighted average number of common shares and the dilutive effect of all securities outstanding. Reconciliation between basic and diluted net income (loss) per share is as follows: Fiscal Year Ended July 31, 2016 2015 2014 (in thousands, except per share data) Net income (loss) $ 11,174 $ 28,226 $ 833 Basic EPS Weighted average shares outstanding—basic 53,783 53,658 48,214 Basic EPS $ 0.21 $ 0.53 $ 0.02 Diluted EPS Weighted average shares outstanding—basic 53,783 53,658 48,214 Plus: impact of stock options and unvested restricted stock units 191 873 936 Weighted average shares outstanding—diluted 53,974 54,531 49,150 Diluted EPS $ 0.21 $ 0.52 $ 0.02 For the fiscal years ended July 31, 2016, 2015 and 2014, options to purchase approximately 0.0 million, 0.1 million, and 0.4 million shares, respectively, of common stock were not included in the calculation of diluted earnings per share because the effect of including the options would have been anti-dilutive. As of July 31, 2016 there were no remaining options outstanding. In accordance with the contingently issuable shares guidance of the FASB ASC Topic 260, Earnings Per Share Cash and Cash Equivalents and Marketable Securities The Company considers all highly liquid investments that are readily convertible to cash and that have original maturity dates of three months or less to be cash equivalents. Cash and cash equivalents consist primarily of operating cash, money market accounts and reverse repurchase agreements. Marketable securities consist primarily of debt securities that are classified as available-for-sale, in accordance with Topic 320, Investments—Debt and Equity Securities, The market value and maturities of the Company’s marketable securities are as follows: Total Amount (in thousands) July 31, 2016 Due in less than one year $ 25,257 Due in 1 to 3 years 31,099 Total marketable securities $ 56,356 Total Amount (in thousands) July 31, 2015 Due in less than one year $ 36,447 Due in 1 to 3 years 24,146 Total marketable securities $ 60,593 The market value and amortized cost of marketable securities are as follows: Market Amortized (in thousands) July 31, 2016 Corporate (a) $ 22,574 $ 22,405 Government 18,321 18,249 Mortgage-Backed 1,665 1,672 Asset-Backed 13,796 13,739 Total $ 56,356 $ 56,065 Market Amortized (in thousands) July 31, 2015 Corporate (a) $ 15,996 $ 15,951 Government 25,567 25,381 Mortgage-Backed 2,670 2,674 Asset-Backed 16,360 16,335 Total $ 60,593 $ 60,341 (a) There are no held to maturity investments included in the above figures as of July 31, 2016 and 2015, respectively. Realized gains, losses and interest income are included in interest income in the Statements of Operations. Unrealized gains and losses are reflected as a separate component of comprehensive income (loss) within Stockholders’ Equity. The Company analyzes its securities portfolio for other-than-temporary impairment on a quarterly basis or upon occurrence of a significant change in circumstances. There were no other-than-temporary impairment losses recorded in the fiscal years ended July 31, 2016 or 2015. The following table summarizes marketable securities and related unrealized gains and losses as of July 31, 2016 and 2015: July 31, 2016 Market Unrealized (in thousands) Securities < 12 months unrealized losses $ 3,363 $ (4 ) Securities > 12 months unrealized losses 6,925 (17 ) Securities < 12 months unrealized gains 21,894 19 Securities > 12 months unrealized gains 24,174 74 Total $ 56,356 $ 72 July 31, 2015 Market Unrealized (in thousands) Securities < 12 months unrealized losses $ 17,767 $ (28 ) Securities > 12 months unrealized losses 11,592 (23 ) Securities < 12 months unrealized gains 18,681 12 Securities > 12 months unrealized gains 12,553 20 Total $ 60,593 $ (19 ) Interest income and realized gains and losses from sales of marketable securities, included in interest income in the Statement of Operations, are as follows: Fiscal Year Ended July 31, 2016 2015 2014 (in thousands) Interest income on marketable securities $ 280 $ 1,221 $ 1,326 Realized gain (loss) from sales of securities (1 ) 22 16 Total $ 279 $ 1,243 $ 1,342 Fair Value of Financial Instruments The Company determines its fair value measurements for assets and liabilities based upon the provisions of Topic 820, Fair Value Measurements and Disclosures, Topic 825 to the FASB ASC, Financial Instruments, Concentration of Credit and Supplier Risk Fiscal Year Ended July 31, 2016 2015 2014 (in millions except %’s) Revenue from top ten customers 55 % 54 % 51 % Accounts receivable from the same top ten customers $ 42.3 $ 43.1 $ 48.6 Sales to customers outside the United States $ 266.0 $ 312.5 $ 239.2 Financial instruments, which potentially subject the Company to concentrations of credit risk, are cash equivalents, marketable securities and accounts receivable. All of the Company’s cash equivalents and marketable securities are maintained by major financial institutions. The Company periodically reviews these investments to evaluate and minimize credit risk. Concentration of credit risk with respect to accounts receivable is limited to certain customers to whom the Company makes substantial sales. To reduce risk, the Company routinely assesses the financial strength of its customers. The Company does not require collateral, although the Company does obtain letters of credit on sales to certain foreign customers. During fiscal 2016 the Company did not write off any accounts receivable. During fiscal 2015, the Company wrote off $0.1 million of accounts receivable. There were no write-offs for the fiscal year ended July 31, 2014. The Company outsources certain components and subassemblies for our test equipment to contract manufacturers other than its sole source supplier manufacturer. The Company’s products incorporate standard components and prefabricated parts manufactured to its specifications. These components and subassemblies are used to produce testers in configurations specified by its customers. Some of the standard components for the Company’s products are available from a number of different suppliers; however, many such standard components are purchased from a single supplier or a limited group of suppliers. Although the Company believes that all single sourced components currently are available in adequate amounts, shortages or delivery delays may develop in the future. The Company is dependent on certain semiconductor device manufacturers, who are sole source suppliers of custom components for its products. The Company has no written supply agreements with these sole source suppliers and purchases its custom components through individual purchase orders. The Company continuously evaluates alternative sources for the manufacture of our custom components and the supply of our standard components; however, such alternative sources may not meet its required qualifications or have capacity that is available to the Company. Property and Equipment Property and equipment acquired is recorded at cost. The Company provides for depreciation and amortization using the straight-line method. Charges are made to operating expenses in amounts that are sufficient to amortize the cost of the assets over their estimated useful lives. Equipment spares used for service and internally manufactured test systems used for testing components and engineering projects are recorded at cost and depreciated over three to seven years. Repair and maintenance costs that do not extend the lives of property and equipment are expensed as incurred. The Company’s property and equipment as of July 31, 2016 and July 31, 2015 are summarized as follows: As of July 31, Estimated Useful 2016 2015 (in thousands) (in years) Equipment spares $ 30,784 $ 41,398 7 Machinery, equipment and internally manufactured systems 31,206 32,068 3-7 Office furniture and equipment 2,157 2,518 3-7 Purchased software 725 506 3 Land 2,508 6,106 — Buildings 7,944 8,634 10 – 40 years Leasehold improvements 10,312 11,029 Term of lease or exceed 10 years Property and equipment, gross $ 85,636 102,259 Accumulated depreciation and amortization (60,153 ) (70,809 ) Property and equipment, net $ 25,483 $ 31,450 During the fiscal year ended July 31, 2016 the Company executed two purchase and sale agreements for land owned in Hillsboro, Oregon. As a result these assets have been moved to Assets Held for Sale on the Company’s Consolidated Balance Sheet as of July 31, 2016. The Company expects the sale transactions to be complete during the fiscal year ending July 31, 2017. Depreciation expense was $5.7 million, $6.4 million, and $6.1 million for the fiscal years ended July 31, 2016, 2015, and 2014, respectively. Recent Accounting Pronouncements In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), In April 2015, the FASB issued ASU No. 2015-03, Interest – Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs In September 2015, the FASB issued ASU No. 2015-16, Simplifying the Accounting for Measurement-Period Adjustments In November 2015, the Financial Accounting Standards Board issued Accounting Standards Update 2015-17, “Balance Sheet Classification of Deferred Taxes”, which requires that all deferred tax assets and liabilities be classified as non-current on the balance sheet. The amendments in ASU 2015-17 are intended to simplify the presentation of deferred income taxes. As of July 31, 2016, the Company has adopted ASU 2015-17 on a prospective basis and has not adjusted prior periods as a result of the adoption. As required by ASU 2015-17, all deferred tax assets and liabilities are now classified as non-current in the Company’s consolidated balance sheets. In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), In March 2016, the FASB issued ASU 2016-09, “Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting.” |